ArticleMolecular therapy : the journal of the American Society of Gene Therapy2010

Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.

Damien Bresson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.